Postoperative Acute Kidney Injury After Transcatheter Aortic Valve Replacement
Authors:
Open Access
- 1 April 2024
- journal article
- review article
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 14 (2) , 312-317
Abstract
Purpose of Review: The purpose of this review serves to briefly summarize the current literature surveying the incidence of posttranscatheter aortic valve replacement acute kidney injury (TAVR AKI). Furthermore, this review extends itself to evaluate and potentially address modifiable risk factors, while acknowledging non-modifiable risk factors in the perioperative setting. These modifiable risk factors include but are not limited to access method, perioperative hypotension events, and need for blood transfusion in the setting of preoperative anemia. Recent Findings: Recent retrospective studies have highlighted the incidence of post-TAVR AKI, citing as high as 1 in 6 patients. Despite exclusion of patients with end-stage renal disease (ESRD) from pivotal TAVR trials, data shows that over 50% of high-risk patients suffer > 3a chronic kidney disease (CKD) and about 10% of them suffer > 4 CKD, with the risk of AKI increasing significantly at each stage of CKD advancement. Meta-analyses have shown that patients who underwent TAVR via transfemoral (TF) approach compared to those who had transapical (TA) or transaortic (TaO) approach had significantly less AKI post-TAVR. Furthermore, in patients who developed post-TAVR AKI, 55% of them had received packed red blood cell (pRBC) transfusion, while only 21% of the patients who did not receive pRBCs develop post-TAVR AKI (p = .002). Post-TAVR AKI has been shown in multiple studies that it is an independent risk factor for increased short term and long-term mortality. These findings together highlight both the clinical significance and continued perioperative vigilance to further improve clinical outcomes. Summary: This review aims to summarize recent literature regarding the association of AKI in the perioperative setting of TAVR. In addition, it parses the risk factors into both modifiable and non-modifiable risk factors. Furthermore, it provides some recommendations including procedure approach, appreciating transfusion implication, and most importantly, preventing hypotension events in the perioperative period.Keywords
This publication has 23 references indexed in Scilit:
- Acute Kidney Injury and TAVR: Time to Turn Down the (Contrast) VolumeJournal of the Society for Cardiovascular Angiography & Interventions, 2022
- Association between mid‐term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney diseaseCatheterization and Cardiovascular Interventions, 2020
- Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk PatientsNew England Journal of Medicine, 2019
- Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patientsEuropean Radiology, 2018
- Temporal Trends in Transcatheter Aortic Valve Replacement in FranceJACC, 2017
- Independent Risk Factors Contributing to Acute Kidney Injury According to Updated Valve Academic Research Consortium-2 Criteria After Transcatheter Aortic Valve Implantation: A Meta-analysis and Meta-regression of 13 StudiesJournal of Cardiothoracic and Vascular Anesthesia, 2017
- Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trialThe Lancet, 2017
- Incidence and predictors of acute kidney injury after transcatheter aortic valve replacementAmerican Heart Journal, 2012
- Acute Kidney Injury in the ElderlyClinics in Geriatric Medicine, 2009
- Valvular Aortic StenosisJACC, 2006